Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLNCF) Deferred Taxes (2024 - 2025)

Historic Deferred Taxes for Silence Therapeutics (SLNCF) over the last 2 years, with Q3 2025 value amounting to $1000.0.

  • Silence Therapeutics' Deferred Taxes fell 9795.92% to $1000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $335000.0, marking a year-over-year change of. This contributed to the annual value of $845000.0 for FY2024, which is 1161.09% down from last year.
  • Per Silence Therapeutics' latest filing, its Deferred Taxes stood at $1000.0 for Q3 2025, which was down 9795.92% from $10000.0 recorded in Q2 2025.
  • Silence Therapeutics' Deferred Taxes' 5-year high stood at $324000.0 during Q4 2024, with a 5-year trough of $1000.0 in Q3 2025.